鄭孟軒 副教授 

分機：07-3121101轉5651

E-Mail：cmhkmu@kmu.edu.tw

高醫附院胸腔內科

職稱

副教授

學歷/經歷

高雄醫學大學 醫學研究所博士

高雄醫學大學 附設中和紀念醫院肺功能室主任

高雄醫學大學 內科學助理教授

署立屏東醫院 內科部主任

署立屏東醫院 內科加護病房主任

高雄醫學大學 附設中和紀念醫院/內科加護病房專責主治醫師

高雄醫學大學 附設中和紀念醫院總住院醫師

高雄醫學大學附設中和紀念醫院住院醫師

專長領域

內科

胸腔內科

重症醫學

肺結核及一般感染症

授課科目

長期呼吸照護學

長期呼吸照護學實習

期刊論文

1.    Cheng MH, Wang HH, Hua MD, Kuo HF, Lin ZJ, Hsieh CC, Hsu CH, Li CY, Wang SC, Chen YH, Wu SH, Liu WL, Liu PL. *. (2025 Jun). Magnolol facilitates mitochondrial-peroxisome dysfunction and induces oxeiptosis in lung cancer cells following transfer via tunneling nanotubes. Biomed Pharmacother, 187:118126. 本人為第一作者

2.    Huang HL, Cheng MH, Lee MR, Chien JY, Lu PL, Sheu CC, Wang JY, Chong IW, Yang JM, Huang WC. (2025 Dec). Prevalence and treatment outcomes of latent tuberculosis infection among older patients with chronic obstructive pulmonary disease in an area with intermediate tuberculosis burden. Emerg Microbes Infect. 2025 Dec;14(1):2497302.

3.    Huang HL, Lin CH, Lee MR, Huang WC, Sheu CC, Cheng MH, Lu PL, Huang CH, Yeh YT, Yang JM, Chong IW, Liao YC, Wang JY. (2024 Dec). Sputum bacterial microbiota signature as a surrogate for predicting disease progression of nontuberculous mycobacterial lung disease. Int J Infect Dis. 149:107085.

4.    Liu KY, Sie JJ, Gao Y, Lo YL, Wu CC, Wang CC, Sheu CC, Lai RS, Leung SY, Lin CC, Wei YF, Lin CH, Lin SH, Hsu JY, Huang WC, Tseng CC, Lai YF, Cheng MH, Chen HC, Yang CJ, Hsu YT, Su CH, Hsu SC, Chung WY, Hsieh MT, Chen LC, Hung CH, Lee CL, Huang MS, Zhou Y, Fann CSJ, Huang SK. (2025 Jul). Functional sequence variants of intergenic long non-coding RNA on Chromosome 17q21 are associated with asthma. Eur Respir J. 2025 3:2500847.

5.    Hsu YT, Wu CC, Wang CC, Sheu CC, Yang YH, Cheng MY, Lai RS, Cheng MH, Chen HC, Yang CJ, Wang CJ, Liu HJ, Chen HL, Hung CH, Lee CL, Huang MS, Huang SK. (2025 Apr) Differential Risks of Exposure to Acrylamide in Adult Asthma Clusters. Allergy.;80(4):1173-1175.

6.    Chen YF, Chang CL, Hou HH, Chien N, Lu KZ, Chen YY, Hung ZC, Hsiao YH, Sheu CC, Wang PH, Hsieh MH, Hsu WH, Chen MT, Ou WF, Wei YF, Yang TM, Lan CC, Wang CY, Lin CB, Lin MS, Wang YT, Lin CH, Liu SF, Cheng MH, Cheng WC, Peng CK, Chan MC, Chen CY, Jao LY, Wang YH, Chen CJ, Chen SP, Tsai YH, Cheng SL, Lin HC, Chien JY, Wang HC, Yu CJ. (2025 Mar). The impact of COPD-bronchiectasis association on clinical outcomes: insights from East Asian cohorts validating the ROSE criteria. ERJ Open Res. 10;11(2):00626-2024.

7.    Wang PH, Shu CC, Sheu CC, Chang CL, Hsieh MH, Hsu WH, Chen MT, Ou WF, Wei YF, Yang TM, Lan CC, Wang CY, Lin CB, Lin MS, Wang YT, Lin CH, Liu SF, Cheng MH, Chen YF, Cheng WC, Peng CK, Chan MC, Chen CY, Jao LY, Wang YH, Chen CJ, Chen SP, Tsai YH, Cheng SL, Lin HC, Chien JY, Wang HC. (2024 Jul). Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis. Open Forum Infect Dis. 18;11(8): ofae427.

8.    Cheng MH, Kuo HF, Chang CY, Chang JC, Liu IF, Hsieh CC, Hsu CH, Li CY, Wang SC, Chen YH, Chang CR, Lee TY, Liu YR, Huang CY, Wu SH, Liu WL, Liu PL. (2024 May). Curcumin regulates pulmonary extracellular matrix remodeling and mitochondrial function to attenuate pulmonary fibrosis by regulating the miR-29a-3p/DNMT3A axis. Biomed Pharmacother, 174:116572. 本人為第一作者

9.    Huang HL, Lee MR, Lee CH, Cheng MH, Lu PL, Sheu CC, Wang JY, Chong IW, Yang JM. (2024 Nov). One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial. Clin Microbiol Infect.;30(11):1410-1417.

10.  Lee MR, Huang HL, Huang WC, Wu SY, Liu PC, Wu JC, Cheng MH, Sheu CC, Tang KT, Wang JY, Ho CC, Shih JY, and Chong IW. (2023 Sep). Electronic nose in differentiating and ascertaining clinical status among patients with pulmonary nontuberculous mycobacteria: A prospective multicenter study. J Infect, 87(3):255-258.

11.  Hsu YT, Wu CC, Wang CC, Chung WY, Sheu CC, Yang YH, Cheng MY, Lai RS, Leung SY, Lin CC, Wei YF, Lin CH, Lin SH, Hsu JY, Huang WC, Tseng CC, Lai YF, Cheng MH, Chen HC, Yang CJ, Su CH, Wang CJ, Hsu SC, Hung CH, Lee CL, Huang MS, and Huang SK. (2023 Jul). BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters. Allergy, 78(7):2036-2040.

12.  Wu CC, Wang CC, Chung WY, Sheu CC, Yang YH, Cheng MY, Lai RS, Leung SY, Lin CC, Wei YF, Lin CH, Lin SH, Hsu JY, Huang WC, Tseng CC, Lai YF, Cheng MH, Chen HC, Yang CJ, Hsu SC, Su CH, Wang CJ, Liu HJ, Chen HL, Hsu YT, Hung CH, Lee CL, Huang MS, and Huang SK. (2023 Mar). Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study. Thorax, 78(3):225-232.

13.  Huang HL, Luo YC, Lu PL, Huang CH, Lin KD, Lee MR, Cheng MH, Yeh YT, Kao CY, Wang JY, Yang JM, and Chong IW. (2023 Jan). Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes. Respir Res, 24(1):11.

14.  Huang HL, Lee JY, Lo YS, Liu IH, Huang SH, Huang YW, Lee MR, Lee CH, Cheng MH, Lu PL, Wang JY, Yang JM, and Chong IW. (2022 Sep). Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy. Clin Infect Dis, 75(5):743-752.

15.  Chung CL, Huang WC, Huang HL, Chin CS, Cheng MH, Lee MR, Lin SH, Wang JY, Lin CH, Chong IW, Shih JY, and Yu CJ. (2021 Nov). Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort Study. Open Forum Infect Dis, 8(12): ofab565.

16.  Huang HL, Huang WC, Lin KD, Liu SS, Lee MR, Cheng MH, Chin CS, Lu PL, Sheu CC, Wang JY, Lee IT, and Chong IW. (2021 Sep). Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study. Clin Infect Dis, 73(6): e1252-e1260.

17.  Huang HL, Lee MR, Cheng MH, Lu PL, Huang CK, Sheu CC, Lai PC, Chen TC, Wang JY*, and Chong IW. (2021 Sep). Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection. Clin Infect Dis, 73(5): e1064-e1071.

18.  Liu WL, Li CY, Cheng WC, Chang CY, Chen YH, Lu CY, Wang SC, Liu YR, Cheng MH*, Chong IW*, and Liu PL*. (2021 Mar). High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1. Int J Mol Sci, 22(7):3628. 本人為通訊作者

19.  Cheng MH, Weng JY, Chuang CH, Liao WT, Lai YF, Liu JY, and Fang YP*. (2020 Sep). Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma. Cancers (Basel), 12(9):2558. 本人為第一作者

20.  Cheng MH, Pan CY, Chen NF, Yang SN. Hsieh SC, Wen ZH, Chen WF Wang JW*, Lu WH*, and Kuo HM*. (2020 Mar). Piscidin-1 Induces Apoptosis via Mitochondrial Reactive Oxygen Species-Regulated Mitochondrial Dysfunction in Human Osteosarcoma Cells. Sci Rep, 10(1):5045. 本人為第一作者

21.  Chou PL, Huang YP, Cheng MH, Rau KM, Fang YP*. (2020 Mar). Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis. Int J Nanomedicine, 15:1731-1743.

22.  Lee MR, Huang HL, Chen LC, Yang HC, Ko JC, Cheng MH, Chong IW, Lee LN, Wang JY*, Dimopoulos G*. (2020 Aug). Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study. Clin Microbiol Infect, 26(8): 1091.e1-1091.e7.

23.  Huang HL, Lee MR, Liu CJ, Cheng MH, Lu PL, Wang JY*, Chong IW*. (2020 Jan). Predictors of radiographic progression for NTM-pulmonary disease diagnosed by bronchoscopy. Respir Med, 161:105847.

24.  Cheng MH, Huang HL, Lin YY, Tsui KH, Chen PC, Cheng SY, Chong IW, Sung PJ, Tai MH, Wen ZH, Chen NF*, Kuo HM*. (2019 May). BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells. Oxid Med Cell Longev, 2019:6342104. 本人為第一作者

25.  Liu CJ, Huang HL, Cheng MH, Lu PL, Shu CC, Wang JY Chong IW*. (2019 May). Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease. Respir Med, 151:19-26.

二、近三年所有研究計畫

三、專利：

請填入目前仍有效之專利。「類別」請填入代碼：(A)發明專利(B)新型專利(C)新式樣專利。